arrow
S

Suzuki, Kazushi

Department of Pathology and Clinical Laboratories
H指数:0
被引数:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Extranodal extension in lung adenocarcinoma: pathological insights and its implication as a histological marker of clinical aggressiveness

肺腺癌中的结外侵犯:病理学见解及其作为临床侵袭性组织学标志物的意义

2025-12-160
PRE
The relationship of soluble tau species with Alzheimer's disease amyloid plaque removal and tau pathology

可溶性tau物种与阿尔茨海默病淀粉样斑块清除及tau病理的关系

2025-09-230
OAAI
Regional effects of gantenerumab on neuroimaging biomarkers in the DIAN-TU-001 trial

gantenerumab在DIAN-TU-001试验中对神经影像生物标志物的区域性影响

2025-07-140
OA
Immunohistochemical evaluation of a trial of gantenerumab or solanezumab in dominantly inherited Alzheimer disease

显性遗传阿尔茨海默病中gantenerumab或solanezumab试验的免疫组化评估

2025-06-030
OAAI
Clinicopathological features of anti-HMGCR and anti-SRP myopathies that do not satisfy the EULAR/ACR criteria of inflammatory myopathies

抗HMGCR和抗SRP肌病的临床病理特征,这些肌病不符合EULAR/ACR炎症性肌病诊断标准

2025-04-030
PRE
Combining plasma Aβ and p-tau217 improves detection of brain amyloid in non-demented elderly

血浆a β 和p-tau217的结合可改善非痴呆老年人脑淀粉样蛋白的检测

2024-05-239
OAAI
Examining amyloid reduction as a surrogate endpoint through latent class analysis using clinical trial data for dominantly inherited Alzheimer's disease
2024-02-231
OAAI
Cross-sectional and longitudinal comparisons of biomarkers and cognition among asymptomatic middle-aged individuals with a parental history of either autosomal dominant or late-onset Alzheimer's disease
2023-01-144
OA
Amyloid-Related Imaging Abnormalities in the DIAN-TU-001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease
2022-10-1324
OA